Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Modafinil: a review of neurochemical actions and effects on cognition.

Minzenberg MJ, Carter CS.

Neuropsychopharmacology. 2008 Jun;33(7):1477-502. Epub 2007 Aug 22. Review.

2.

A systematic review of modafinil: Potential clinical uses and mechanisms of action.

Ballon JS, Feifel D.

J Clin Psychiatry. 2006 Apr;67(4):554-66. Review.

PMID:
16669720
3.

Cognitive enhancing effects of modafinil in healthy volunteers.

Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ.

Psychopharmacology (Berl). 2003 Jan;165(3):260-9. Epub 2002 Nov 1.

PMID:
12417966
4.

Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain.

Scoriels L, Jones PB, Sahakian BJ.

Neuropharmacology. 2013 Jan;64:168-84. doi: 10.1016/j.neuropharm.2012.07.011. Epub 2012 Jul 20. Review.

PMID:
22820555
5.

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia.

Turner DC, Clark L, Pomarol-Clotet E, McKenna P, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2004 Jul;29(7):1363-73.

6.

The vigilance promoting drug modafinil modulates serotonin transmission in the rat prefrontal cortex and dorsal raphe nucleus. Possible relevance for its postulated antidepressant activity.

Ferraro L, Antonelli T, Beggiato S, Cristina Tomasini M, Fuxe K, Tanganelli S.

Mini Rev Med Chem. 2013 Apr;13(4):478-92. Review.

PMID:
22512571
7.

Acute modafinil effects on attention and inhibitory control in methamphetamine-dependent humans.

Dean AC, Sevak RJ, Monterosso JR, Hellemann G, Sugar CA, London ED.

J Stud Alcohol Drugs. 2011 Nov;72(6):943-53.

8.

Modulatory effects of modafinil on neural circuits regulating emotion and cognition.

Rasetti R, Mattay VS, Stankevich B, Skjei K, Blasi G, Sambataro F, Arrillaga-Romany IC, Goldberg TE, Callicott JH, Apud JA, Weinberger DR.

Neuropsychopharmacology. 2010 Sep;35(10):2101-9. doi: 10.1038/npp.2010.83. Epub 2010 Jun 16.

9.

Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.

Saavedra-Velez C, Yusim A, Anbarasan D, Lindenmayer JP.

J Clin Psychiatry. 2009 Jan;70(1):104-12. Epub 2008 Nov 18. Review.

PMID:
19026265
10.

Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.

Battleday RM, Brem AK.

Eur Neuropsychopharmacol. 2015 Nov;25(11):1865-81. doi: 10.1016/j.euroneuro.2015.07.028. Epub 2015 Aug 20. Review.

PMID:
26381811
11.

A review of the effects of modafinil on cognition in schizophrenia.

Morein-Zamir S, Turner DC, Sahakian BJ.

Schizophr Bull. 2007 Nov;33(6):1298-306. Epub 2007 Jul 18. Review.

12.

Modafinil modulation of the default mode network.

Minzenberg MJ, Yoon JH, Carter CS.

Psychopharmacology (Berl). 2011 May;215(1):23-31. doi: 10.1007/s00213-010-2111-5. Epub 2010 Dec 14.

13.

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.

Turner DC, Clark L, Dowson J, Robbins TW, Sahakian BJ.

Biol Psychiatry. 2004 May 15;55(10):1031-40.

PMID:
15121488
14.

Modafinil, but not escitalopram, improves working memory and sustained attention in long-term, high-dose cocaine users.

Kalechstein AD, Mahoney JJ 3rd, Yoon JH, Bennett R, De la Garza R 2nd.

Neuropharmacology. 2013 Jan;64:472-8. doi: 10.1016/j.neuropharm.2012.06.064. Epub 2012 Jul 13.

PMID:
22796108
15.

Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia.

Rosenthal MH, Bryant SL.

Clin Neuropharmacol. 2004 Jan-Feb;27(1):38-43.

PMID:
15090936
16.

Effect of modafinil on cognitive functions in alcohol dependent patients: a randomized, placebo-controlled trial.

Joos L, Goudriaan AE, Schmaal L, van den Brink W, Sabbe BG, Dom G.

J Psychopharmacol. 2013 Nov;27(11):998-1006. doi: 10.1177/0269881113503505. Epub 2013 Sep 17.

PMID:
24045883
17.

Modafinil combined with cognitive training is associated with improved learning in healthy volunteers--a randomised controlled trial.

Gilleen J, Michalopoulou PG, Reichenberg A, Drake R, Wykes T, Lewis SW, Kapur S.

Eur Neuropsychopharmacol. 2014 Apr;24(4):529-39. doi: 10.1016/j.euroneuro.2014.01.001. Epub 2014 Jan 16.

PMID:
24485800
18.

Use of modafinil for the treatment of attention deficit/hyperactivity disorder.

Lindsay SE, Gudelsky GA, Heaton PC.

Ann Pharmacother. 2006 Oct;40(10):1829-33. Epub 2006 Sep 5. Review.

PMID:
16954326
19.

The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia.

Perlis ML, Smith MT, Orff H, Enright T, Nowakowski S, Jungquist C, Plotkin K.

Sleep. 2004 Jun 15;27(4):715-25.

PMID:
15283007
20.

Differences in the neurochemical and behavioural profiles of lisdexamfetamine methylphenidate and modafinil revealed by simultaneous dual-probe microdialysis and locomotor activity measurements in freely-moving rats.

Rowley HL, Kulkarni RS, Gosden J, Brammer RJ, Hackett D, Heal DJ.

J Psychopharmacol. 2014 Mar;28(3):254-69. doi: 10.1177/0269881113513850. Epub 2013 Dec 10.

PMID:
24327450

Supplemental Content

Support Center